Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study.

Subclinical hypothyroidism (SCH) is defined as an asymptomatic state characterized by normal serum levels of free thyroxine and elevated serum concentrations of thyrotropin (> 4.0 µU/ml). The association between SCH and type 2 diabetes has been well established. Proliferative diabetic retinopathy (PDR) that is characterized by neovascularization is a leading cause of visual loss in adults worldwide. However, whether SCH is related to PDR has not been studied. This study thus aimed to evaluate the relationship between SCH and PDR in type 2 diabetes. A total of 371 type 2 diabetic subjects were enrolled: 187 subjects with PDR and 184 subjects without diabetic retinopathy (with HbA1c above 6.5% and at least 10 years of diabetes duration). Subjects with PDR had higher blood pressure, higher serum levels of total cholesterol, low-density lipoprotein cholesterol and thyrotropin, and higher urinary albumin excretion rate. Of the 371 diabetics, 83 subjects (22.4%) were diagnosed as SCH (male 12.1% and female 29.9%). The prevalence of SCH in the PDR group (51/187, 27.3%) was higher than that in the subjects without diabetic retinopathy (32/184, 17.4%). Logistic regression analysis showed that after adjusting for compounding variables, SCH was independently related with PDR (p = 0.032, adjusted OR = 2.485). These results indicate that type 2 diabetic patients with PDR are at an increased risk of SCH. A routine screening for thyroid function may thus be considered advisable in PDR subjects. This may be helpful in investigating new strategies preventing or treating PDR in clinical practice.

[1]  J. Franklyn,et al.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.

[2]  Wei Liu,et al.  An Association Between Subclinical Hypothyroidism and Sight-Threatening Diabetic Retinopathy in Type 2 Diabetic Patients , 2010, Diabetes Care.

[3]  T. Economopoulos,et al.  Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. , 2009, European journal of endocrinology.

[4]  C. Sweep,et al.  Thyroid function in patients with proteinuria. , 2008, The Netherlands journal of medicine.

[5]  Silvio E. Inzucchi,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[6]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[7]  T. Jap,et al.  Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[8]  A. Oguz,et al.  Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. , 2007, Endocrine journal.

[9]  S Kumar,et al.  Type 2 diabetes and cardiovascular risk in the UK south Asian community , 2006, Diabetologia.

[10]  T. Davis,et al.  Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  J. Holmes,et al.  The Effect of L-Thyroxine Supplementation on Retinal Vascular Development in Neonatal Rats , 2005, Current eye research.

[12]  J. Holmes,et al.  The anti-thyroid drug methimazole induces neovascularization in the neonatal rat analogous to ROP. , 2004, Investigative ophthalmology & visual science.

[13]  C. Palombo,et al.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.

[14]  B. Berkowitz,et al.  Effect of methylimidazole-induced hypothyroidism in a model of low retinal neovascular incidence. , 2004, Investigative ophthalmology & visual science.

[15]  M. Helfand.  Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.

[16]  L. Ghiadoni,et al.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  L. Demers,et al.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease , 2003, Clinical endocrinology.

[18]  B. Biondi,et al.  Effects of Subclinical Thyroid Dysfunction on the Heart , 2002, Annals of Internal Medicine.

[19]  E. Perez-stable,et al.  Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. , 2002, Archives of internal medicine.

[20]  E. Ferrannini,et al.  Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. , 2002, The Journal of clinical endocrinology and metabolism.

[21]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[22]  H. Milionis,et al.  Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? , 2001, European journal of endocrinology.

[23]  J. Drewe,et al.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). , 2001, The Journal of clinical endocrinology and metabolism.

[24]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[25]  D. Kirsten.  The Thyroid Gland: Physiology and Pathophysiology , 2000, Neonatal Network.

[26]  H. Vierhapper,et al.  Low-density lipoprotein cholesterol in subclinical hypothyroidism. , 2000, Thyroid : official journal of the American Thyroid Association.

[27]  Wilson Dp,et al.  Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity? , 2000 .

[28]  T. Tzotzas,et al.  Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. , 2000, Thyroid : official journal of the American Thyroid Association.

[29]  M. Müllner,et al.  Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. , 2000, Journal of clinical epidemiology.

[30]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[31]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[32]  E. Liberopoulos,et al.  The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. , 1999, Thyroid : official journal of the American Thyroid Association.

[33]  R. Westendorp,et al.  The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case‐finding? , 1999, Clinical endocrinology.

[34]  M. Helfand,et al.  Screening for Thyroid Disease: An Update , 1998, Annals of Internal Medicine.

[35]  M. Smithson,et al.  Screening for thyroid dysfunction in a community population of diabetic patients , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[36]  B. Frier,et al.  Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[37]  D. Fisher.  Euthyroid low thyroxine (T4) and triiodothyronine (T3) states in prematures and sick neonates. , 1990, Pediatric clinics of North America.

[38]  C. Kilo,et al.  Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats. , 1989, Metabolism: clinical and experimental.

[39]  J. Feely,et al.  Screening for thyroid dysfunction in diabetics. , 1979, British medical journal.

[40]  D. Bauer,et al.  Thyroid Studies Collaboration , 2010 .

[41]  D. Wilson,et al.  Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity? , 2000, Texas medicine.

[42]  M. Helfand,et al.  Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. , 1998, Annals of internal medicine.